Cheminnova Remedies Profile
Key Indicators
- Authorised Capital ₹ 4.00 Cr
as on 11-12-2024
- Paid Up Capital ₹ 2.40 Cr
as on 11-12-2024
- Company Age 24 Year, 10 Months
- Last Filing with ROC 31 Mar 2012
- Open Charges ₹ 21.35 Cr
as on 11-12-2024
About Cheminnova Remedies
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2012. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 2.40 Cr.
The company currently has active open charges totaling ₹21.35 Cr.
Vaidyanathan Nateshan and Vasudev Morusupalli serve as directors at the Company.
- CIN/LLPIN
U24230TG2000PTC033347
- Company No.
033347
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Jan 2000
- Date of AGM
28 Sep 2012
- Date of Balance Sheet
31 Mar 2012
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Cheminnova Remedies?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vasudev Morusupalli  | Managing Director | 24-Jan-2000 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vaidyanathan Nateshan | Director | 22-Mar-2012 | Current |
Financial Performance of Cheminnova Remedies.
Enhance accessibility to Cheminnova Remedies's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Cheminnova Remedies?
Unlock access to Cheminnova Remedies's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Bactochem Biologicals Private LimitedActive 12 years 4 monthsVasudev Morusupalli is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Andhra Pradesh State Financial Corporation Creation Date: 02 May 2013 | ₹3.25 Cr | Open |
Andhra Pradesh State Financial Corporation Creation Date: 24 May 2012 | ₹6.00 M | Open |
S E Investments Limited Creation Date: 18 May 2011 | ₹1.40 Cr | Open |
How Many Employees Work at Cheminnova Remedies?
Cheminnova Remedies has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cheminnova Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cheminnova Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
